Titre:
  • Pre-clinical immunogenicity and anti-tumour efficacy of a deleted recombinant human papillomavirus type 16 E7 protein.
Auteur:Hallez, Sophie; Brulet, Jean-Marc; Vandooren, Caroline; Maudoux, Frédéric; Thomas, Séverine; Heinderickx, Michel; Bollen, Alex; Wattiez, Ruddy; Jacquet, Alain
Informations sur la publication:Anticancer research, 24, 4, page (2265-2275)
Statut de publication:Publié, 2004
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Animals
Cancer Vaccines -- genetics
Cancer Vaccines -- immunology
Cancer Vaccines -- pharmacology
Cell Line, Transformed
Interferon-gamma -- biosynthesis
Interferon-gamma -- immunology
Mice
Mice, Inbred C57BL
Neoplasms, Experimental -- immunology
Neoplasms, Experimental -- prevention & control
Neoplasms, Experimental -- virology
Oncogene Proteins, Viral -- genetics
Oncogene Proteins, Viral -- immunology
Papillomaviridae -- genetics
Papillomaviridae -- immunology
Peptide Fragments -- genetics
Peptide Fragments -- immunology
Recombinant Proteins -- genetics
Recombinant Proteins -- immunology
T-Lymphocytes, Cytotoxic -- immunology
Note générale:Journal Article
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0250-7005
info:pmid/15330171